Table 1.
Type 1 diabetic patients | Healthy controls | ||||
---|---|---|---|---|---|
Group A | Group B | Group C | Group D | ||
Months T1D duration; range (mean) | 0–4 (1·8) | 5–9 (5·8) | 10–14 (12·0) | 15–18 (16·4) | – |
Age; range (mean) | 11–18 (12) | 12–18 (15) | 10–18 (14) | 12–16 (14) | 11–15 (14) |
Gender (female/male) | 6/5 | 11/6 | 13/6 | 6/5 | 8/4 |
Subjects total (n) | 11 | 17 | 19 | 11 | 12 |
Fasting C-peptide (pmol/ml); median (range) | 0·33 (0·18–0·47) | 0·43 (0·08–0·97) | 0·28 (0·03–0·55) | 0·33 (0·09–0·92) | – |